TB-500 Injection Site Rotation: A Research Guide

TB-500 injection site rotation means changing the specific subcutaneous spot used for each injection instead of returning to the same location every time. Site rotation is standard practice for any repeated subcutaneous injection, not a rule unique to TB-500. This reference covers why rotation matters, a workable rotation pattern, and the reconstitution math that stays identical no matter which site a dose is drawn to. It is written for research and educational purposes only and is not medical advice.

Why rotate injection sites

TB-500 injection site rotation follows the same logic as any repeated-injection protocol: injecting into the same small patch of tissue over and over is what makes rotation a standard practice in the first place. A site used repeatedly without a break is more likely to become irritated, tender, or develop a firm patch of thickened tissue underneath the skin — the same reasoning behind long-standing insulin-injection guidance to rotate sites rather than reuse one spot. Moving the injection point gives each area time to recover before it takes another draw.

This is a general injection-technique principle that applies to any compound delivered by repeated subcutaneous injection. It has nothing to do with TB-500's chemistry specifically — it is about giving tissue, not the compound, room to recover.

Common subcutaneous sites

Research protocols that use a U-100 insulin syringe for TB-500 typically rotate among a small set of subcutaneous locations:

• Abdomen — avoiding roughly a two-inch ring around the navel
• Front or outer thigh
• Back of the upper arm
• Hip or flank area (sometimes called the "love handle" region)

Each of these areas has enough surface to support several distinct injection points spaced apart from one another, which is what makes a rotation pattern practical.

Injecting at a rotated site

The physical technique stays the same at every site in the rotation. Swab the chosen spot with an alcohol wipe and let it dry. Pinch a fold of skin between two fingers to lift the subcutaneous layer away from the muscle underneath, then insert the needle at an angle suited to the amount of tissue available at that site — thinner areas like the upper arm generally take a shallower angle than the abdomen. Insert the needle, release the pinch, and depress the plunger at a steady, unhurried pace rather than all at once. Withdraw the needle at the same angle it went in, and press a clean gauze or cotton ball against the site briefly rather than rubbing it.

None of that sequence changes across a rotation — swab, pinch, insert, depress, withdraw applies whether the site is the abdomen, the thigh, the arm, or the hip. What changes is only the location, which is the entire point of rotating in the first place.

A simple rotation pattern

A workable approach is to divide the areas above into zones and move to a different zone on a fixed order — for example, cycling abdomen, thigh, upper arm, and hip in sequence rather than picking at random. Within a single zone, space each new injection at least an inch from the last one and from any older mark that hasn't fully faded. Some people keep a short written log of the date and site used, which makes it easy to see which spot is due for a break.

The specific pattern matters less than the habit of never returning to the same exact point twice in a row. A four-zone rotation gives each site roughly three to four injections' worth of recovery time before it's used again, depending on how often the protocol calls for an injection.

The reconstitution math doesn't change with the site

Where a dose is injected has no effect on the reconstitution arithmetic. Concentration is fixed the moment bacteriostatic water is added to the vial — vial mass divided by water volume — and it stays the same for every draw from that vial regardless of which rotated site receives it.

A common reference setup for TB-500 scales water to vial size at 1 mL per 10 mg, holding concentration at 10 mg/mL:

Worked example. A 10 mg TB-500 vial reconstituted with 1 mL of bacteriostatic water gives 10 ÷ 1 = 10 mg/mL. For a 2.5 mg per-injection dose:

Volume = 2.5 mg ÷ 10 mg/mL = 0.25 mL Units = 0.25 mL × 100 = 25 units

That 25-unit draw is exactly the same whether it's injected into the abdomen this time and the thigh next time. Rotating the site changes where the needle goes in — it does not change the concentration in the vial or the units on the syringe.

Signs it's time to skip a site

Set a rotated site aside, rather than reusing it early, if it shows any of the following:

• New redness or swelling that hasn't settled since the last injection there
• A firm lump or thickened patch under the skin
• Noticeable tenderness when the area is pressed

Any of these that persists or worsens is a question for a clinician rather than something to manage by changing the dose or the reconstitution ratio.

Common mistakes

• Reusing the same spot injection after injection. This is the mistake rotation is meant to prevent.
• Injecting too close to a recent mark. Space new injections at least an inch from the last one in the same zone.
• Assuming a different site changes the dose. Site and dose are independent — rotating where you inject never changes how many units a given mg dose requires.
• Not tracking which site was used last. A short log removes the guesswork of which zone is due for a break.

Use the calculator

Whichever site is in rotation, the units on the syringe are set by vial size, water volume, and target dose — never by the injection location. Enter those three numbers into the peptide reconstitution calculator to confirm the exact units for a dose before drawing it. For TB-500 vial sizes and the concentration math behind the numbers used above, see the TB-500 dosage calculator guide. The calculator handles the arithmetic for every draw; TB-500 injection site rotation is a separate habit that protects the tissue those draws go into.